Cardlytics Warns of Major Risks if Bridg Platform Sale to PAR Technology Falls Through

Cardlytics, Inc. (CDLX) has disclosed a new risk, in the Sales & Marketing category.

Cardlytics, Inc. faces significant uncertainty while the pending sale of its Bridg platform to a PAR Technology affiliate remains subject to closing conditions outside its control, which may cause partners to delay or cancel new arrangements and disrupt strategic planning. If the transaction fails to close, the company could incur sunk transaction costs, suffer damage to customer and employee relationships, and experience a decline in its stock price, all of which could materially and adversely affect its business, financial condition and results of operations.

The average CDLX stock price target is $1.13, implying 38.51% upside potential.

To learn more about Cardlytics, Inc.’s risk factors, click here.